## Abstract ^123^I‐labeled fatty acids and ^18^F‐FDG are used as metabolic markers for detecting myocardial abnormalities. However, a ^99m^Tc‐based molecule may find wider application. In the present work, a new ^99m^Tc‐labeled, uni‐positively charged, 16‐carbon fatty acid has been prepared and eva
Synthesis and bio evaluation of a new fatty acid derivative labelled with technetium-99m
✍ Scribed by Anupam Mathur; Madhava B. Mallia; Suresh Subramanian; Sharmila Banerjee; K. Kothari; H. D. Sarma; Meera Venkatesh
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- French
- Weight
- 138 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
^123^I‐iodophenylpentadecanoic acid (IPPA) and ^123^I‐beta‐methyliodophenylpentadecanoic acid (BMIPP) are radiolabelled fatty acid derivatives used for assessment of myocardial viability. Because of limited accessibility of ^123^I in the clinical scenario, a 99m‐technetium‐based agent would be more advantageous. In this context, a xanthate derivative of 15‐hydroxypentadecanoic acid (HPDA) was synthesized for radiolabelling with [^99m^TcN]^2+^ intermediate.
Direct reaction of the HPDA with carbon disulphide in presence of crushed sodium hydroxide in dry tetrahydrofuran resulted in moderate yield of the desired xanthate product. The prepared ligand was radiolabelled with [^99m^TcN]^2+^ intermediate and the resultant complex was characterized by paper electrophoresis and HPLC. The labelled preparation was assessed for its myocardial extraction and retention characteristics using Swiss mice model.
The HPDA xanthate derivative was obtained in a low yield of ∼30%. Labelling via the [^99m^TcN]^2+^intermediate gave more than 95% complexation. During in vivo studies with the [TcN]^2+^ labelled complex maximum heart uptake observed was 3.10%ID/g at 5 min p.i., which cleared out rapidly, with retention of 0.79%ID/g of the activity at 60 min p.i.
The ^99m^TcN‐HPDA xanthate derivative showed some uptake in the heart but rapid wash out and substantial uptake in the background organs (blood, liver and lungs) led to unfavourable critical ratios at all the time points of study. Copyright © 2006 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract To exploit the tissue affinity of compounds for radiopharmaceutical purposes, attachment of chelating groups is usually necessary to facilitate technetium‐99m binding and transport. The chelating group, iminodiacetic acid, previously used to modify lidocaine for hepatobiliary radiophar
## Abstract The synthesis of a novel technetium‐99m labelled derivative of L‐tyrosine as a potential tumour imaging agent for nuclear medicine diagnosis is reported. The synthesis involved the labelling precursor __fac__‐[^99m^Tc(OH~2~)(CO)~3~]^+^ which was synthesized using the commercially availa
## Abstract Radiolabeled fatty acids are used as tracers for myocardial metabolic imaging and currently ^123^I‐iodophenyl pentadecanoic acid (IPPA) or ^123^I‐__β__‐methyl‐iodophenyl pentadecanoic acid (BMIPP) are the agents of choice. However, ^123^I being a cyclotron‐produced isotope, ^99m^Tc‐labe